Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0027819 (
neuroblastoma
)
27,800
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We have identified a novel gap junction gene by searching the human genome sequence database that encodes a protein designated as
connexin31.9
(
Cx31.9
).
Cx31.9
was most homologous to human Cx32.4 and did not cluster with either the purported alpha- or beta-connexin subfamilies. Expression of
Cx31.9
was detected by RT-PCR in human mRNA from several tissues including cerebral cortex, heart, liver, lung, kidney, spleen, and testis. A partial
Cx31.9
sequence was also represented in the human Expressed Sequence Tag database.
Cx31.9
formed intercellular channels in both paired Xenopus oocytes and transfected
neuroblastoma
N2A cells that were distinguished by an apparent low unitary conductance (12-15 pS) and a remarkable insensitivity to transjunctional voltage. In contrast,
Cx31.9
channels were gated by cytoplasmic acidification or exposure to halothane like other connexins.
Cx31.9
was able to form heterotypic channels with the highly voltage-sensitive Xenopus Cx38 (XenCx38), which provides an opportunity to study gating in heterotypic channels formed by hemichannels (connexons) composed of connexins with widely divergent properties. Thus
Cx31.9
is a novel human connexin that forms channels with unique functional properties.
...
PMID:Virtual cloning, functional expression, and gating analysis of human connexin31.9. 1217 52